Advertisement

Socio-economic Impact

  • L. Joseph MeltonIII

Abstract

Osteoporotic fractures pose an enormous public health problem, and a variety of interventions will be needed to reduce their impact. The only rationale for risk assessment is to employ these interventions efficiently. However, screening tests have costs and the long-term benefits of treatment may be uncertain. This creates a need to consider the costs of risk assessment and the costs of treatment as well as the costs of fractures that might be averted.

Keywords

Bone Mineral Density Fracture Risk Hormone Replacement Therapy Osteoporotic Fracture Estrogen Replacement Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. Chrischilles E, Shireman T, Wallace R. (1994) Costs and health effects of osteoporotic fractures. Bone 15: 377–386.PubMedCrossRefGoogle Scholar
  2. Eddy D, Cummings SR, Dawson-Hughes B, Johnston CC, Lindsay R, Melton LJ HI, Slemenda C. (in press) Guidelines for the prevention, diagnosis and treatment of osteoporosis: Cost-effectiveness analysis and review of the evidence. Osteoporosis Int. Google Scholar
  3. Greendale G A, Barrett-Connor E, Ingles S, Haile R. (1995) Late physical and functional effects of osteoporotic fracture in women: The Rancho Bernardo Study. J Am Geriatr Soc 43: 955–961.PubMedGoogle Scholar
  4. Ray NF, Chan JK, Thamer M, Melton LJ III. (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. J Bone Miner Res 12: 24–35.PubMedCrossRefGoogle Scholar
  5. Torgerson DJ, Kanis JA. (1995) Cost-effectiveness of preventing hip fractures in the elderly population using vitamin D and calcium. Q J Med 88: 135–139.Google Scholar
  6. U.S. Congress, Office of Technology Assessment. (1995) Effectiveness and Costs of Osteoporosis Screening and Hormone Replacement Therapy. Volume I: Cost-Effectiveness Analysis, OTA-BP-H-160. U.S. Government Printing Office, Washington, DC.Google Scholar
  7. U.S. Congress, Office of Technology Assessment. (1995) Effectiveness and Costs of Osteoporosis Screening and Hormone Replacement Therapy. Volume II: Evidence on Benefits, Risks, and Costs. OTA-BP-H-144. U.S. Government Printing Office, Washington, DC.Google Scholar

Copyright information

© Springer-Verlag London Limited 1998

Authors and Affiliations

  • L. Joseph MeltonIII

There are no affiliations available

Personalised recommendations